Hu Ma

402 total citations
23 papers, 292 citations indexed

About

Hu Ma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hu Ma has authored 23 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Hu Ma's work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (4 papers). Hu Ma is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (4 papers). Hu Ma collaborates with scholars based in China, Germany and United States. Hu Ma's co-authors include Jianguo Sun, Zhengtang Chen, Xinxin Wang, Jian‐Guo Zhou, Anmei Zhang, Sheng Lin, Sheng Lin, Lei Wu, Lina Peng and Fengyi Zhao and has published in prestigious journals such as Applied Physics Letters, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Hu Ma

21 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hu Ma China 9 193 168 69 42 29 23 292
Feng Du China 9 229 1.2× 164 1.0× 73 1.1× 54 1.3× 15 0.5× 13 364
Abeba Zewdu United States 8 228 1.2× 133 0.8× 53 0.8× 61 1.5× 23 0.8× 10 311
Shupeng Liu China 11 251 1.3× 145 0.9× 45 0.7× 85 2.0× 46 1.6× 27 382
Yunfei Yan China 11 289 1.5× 178 1.1× 53 0.8× 44 1.0× 39 1.3× 27 384
Guifang Ouyang China 10 152 0.8× 76 0.5× 63 0.9× 32 0.8× 46 1.6× 42 276
Haiyun Zhao China 10 304 1.6× 154 0.9× 103 1.5× 51 1.2× 24 0.8× 13 423
Maojun Di China 6 240 1.2× 137 0.8× 101 1.5× 52 1.2× 34 1.2× 16 353
Kevin C. Corn United States 2 165 0.9× 199 1.2× 60 0.9× 62 1.5× 57 2.0× 3 310

Countries citing papers authored by Hu Ma

Since Specialization
Citations

This map shows the geographic impact of Hu Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hu Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hu Ma more than expected).

Fields of papers citing papers by Hu Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hu Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hu Ma. The network helps show where Hu Ma may publish in the future.

Co-authorship network of co-authors of Hu Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Hu Ma. A scholar is included among the top collaborators of Hu Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hu Ma. Hu Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ling, Yang, Yue Huang, Minjun Chen, et al.. (2025). β-catenin is a Potential Prognostic Biomarker in Uterine Sarcoma. Technology in Cancer Research & Treatment. 24. 2244087096–2244087096.
3.
Shen, Shasha, Tingting Shen, Landong Li, et al.. (2025). Nutritional risk, functional decline, and symptom burden in lung cancer: a study based on PG-SGA scores and biochemical data. Frontiers in Nutrition. 12. 1545177–1545177. 1 indexed citations
4.
Ma, Hu, Shuaichen Jin, Linchuan Li, et al.. (2025). Association between triglyceride-glucose related indices and at-risk NASH in U.S. adults with NAFLD: results from NHANES 2017-2020. Frontiers in Endocrinology. 16. 1604991–1604991. 1 indexed citations
5.
6.
Wang, Shixiang, Yi Xiong, Haitao Wang, et al.. (2024). TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 12(1). e008040–e008040. 7 indexed citations
7.
Yu, Miao, Meng Dong, Qiyin Zhou, et al.. (2024). Single-cell RNA-seq reveals FGF12 as a prognostic biomarker in low-grade endometrial stromal sarcoma. Frontiers in Immunology. 15. 1513076–1513076. 2 indexed citations
8.
Ma, Hu, et al.. (2024). Cancer biotherapy: review and prospect. Clinical and Experimental Medicine. 24(1). 114–114. 2 indexed citations
9.
Liu, Qi, et al.. (2024). Comparison of [18F] FDG PET/CT and [18F]FDG PET/MRI in the Detection of Distant Metastases in Breast Cancer: A Meta-Analysis. Clinical Breast Cancer. 25(2). e113–e123.e4. 2 indexed citations
10.
11.
Zhou, Jian‐Guo, Bo Liang, Jianguo Liu, et al.. (2021). Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy. Cells. 10(5). 977–977. 31 indexed citations
12.
Huang, Yi, et al.. (2021). miR-183 promotes radioresistance of lung adenocarcinoma H1299 cells via epithelial-mesenchymal transition. Brazilian Journal of Medical and Biological Research. 54(5). e9700–e9700. 10 indexed citations
13.
Li, Peijie, Jie Luo, Dahai Liu, et al.. (2020). Radiation therapy for patients with brain metastases from non-small cell lung cancer without driven gene mutation. Chinese Medical Journal. 133(19). 2359–2361. 1 indexed citations
14.
Ding, Tingting, Hu Ma, & Jihong Feng. (2019). A three-gene novel predictor for improving the prognosis of cervical cancer. Oncology Letters. 18(5). 4907–4915. 8 indexed citations
15.
Han, Jing, Fengyi Zhao, Jing Zhang, et al.. (2016). miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway. International Journal of Oncology. 48(5). 1855–1867. 56 indexed citations
16.
Wang, Fei, Jian‐Guo Zhou, Yu Zhang, et al.. (2015). The Value of MicroRNA-155 as a Prognostic Factor for Survival in Non-Small Cell Lung Cancer: A Meta-Analysis. PLoS ONE. 10(8). e0136889–e0136889. 24 indexed citations
17.
Ma, Hu. (2014). Effect of Cistanche deserticola Polysaccharides on Expression of CREB in D-galactose Induced Aging Model Mice. Zhongguo shiyan fangjixue zazhi. 2 indexed citations
18.
Sun, Jianguo, Hu Ma, Anmei Zhang, et al.. (2014). Monitoring microRNAs Using a Molecular Beacon in CD133+/CD338+Human Lung Adenocarcinoma-initiating A549 Cells. Asian Pacific Journal of Cancer Prevention. 15(1). 161–166. 12 indexed citations
19.
Ma, Hu, et al.. (2012). Novel molecular beacons to monitor microRNAs in non-small-cell lung cancer. Molecular and Cellular Probes. 26(5). 182–187. 23 indexed citations
20.
Lin, Sheng, Jianguo Sun, Jingbo Wu, et al.. (2012). Aberrant microRNAs Expression in CD133+/CD326+ Human Lung Adenocarcinoma Initiating Cells from A549. Molecules and Cells. 33(3). 277–284. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feng Du Breakdown of academic impact, for papers by Abeba Zewdu Breakdown of academic impact, for papers by Shupeng Liu Breakdown of academic impact, for papers by Yunfei Yan Breakdown of academic impact, for papers by Guifang Ouyang Breakdown of academic impact, for papers by Haiyun Zhao Breakdown of academic impact, for papers by Maojun Di Breakdown of academic impact, for papers by Kevin C. Corn
Rankless by CCL
2026